Sort
141,003 grants matching “cytokine”
Natural Immunity Against Chlamydia trachomatis
$749,839Toni Darville · Univ Of North Carolina Chapel Hill · R01 · FY2017 · AI
Functional Analysis of Complement Variants in a Genotyped iPSC Epithelial Cell Model System
$749,831Dwight E Stambolian · University Of Pennsylvania · R01 · FY2025 · AI
A NOVEL STRATEGY TO INHIBIT SARS-COV-2 INFECTION AND COVID-19
$749,787Philippe Andre Gallay · Scripps Research Institute, The · R01 · FY2025 · AI
Redefining Clinical Viscosity in Sickle Cell Diseaseby Leveraging Microfluidic Technologies
$749,772Wilbur A Lam · Emory University · R01 · FY2019 · HL
Targeting Dysregulated Maturation Program in PSC-Cardiomyocytes
$749,769Chulan Kwon · Johns Hopkins University · R01 · FY2024 · HL
Targeting Dysregulated Maturation Program in PSC-Cardiomyocytes
$749,769Chulan Kwon · Johns Hopkins University · R01 · FY2025 · HL
Tuberculosis Immunopathogenesis During Superinfection with SARS-CoV2
$749,747Adel M Talaat · University Of Wisconsin-Madison · R01 · FY2025 · AI
Novel Drug Carrier System for the Treatment of Alcoholic Liver Disease
$749,725Philip Bauer · Endoprotech, Inc. · R44 · FY2016 · AA
Preventing and Reducing HAND by Using New BDNF Nanoprobes
$749,720Franco Vitaliano · Exqor Technologies, Inc. · R44 · FY2019 · MH
Mechanistic Studies of NAD+/NADH in Human Heart Failure
$749,718Kevin D. O'Brien · University Of Washington · R01 · FY2023 · HL
New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease
$749,693Franco Vitaliano · Exqor Technologies, Inc. · R44 · FY2018 · AG
Development of a novel vaccine platform: Surface Antigen/Adjuvant Vaccine Engineering (SAAVE)
$749,669Michael Stephen Trent · University Of Georgia · R01 · FY2020 · AI
Investigation of endogenous retroelements in lung disease [OAR project]
$749,669Michael B Fessler · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Immunologic changes associated with three progestin-based contraceptives: characterizing immune profiles over one year and identifying factors that may alter HIV risk
$749,597Alicia K Smith · Emory University · R01 · FY2021 · HD
Physical Activity, Energy Balance, and Cancer
$749,585Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
COSTIMULATION IN PERIPHERAL T CELL TOLERANCE AND ANERGY
$749,572University Of California San Francisco · P01 · FY2000 · AI
Human immune signatures of natural immunity to DENV infection, severe disease, and vaccination with attenuated live vaccine
$749,544Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2016 · AI
Sleep and Immune Mechanisms in Rheumatoid Arthritis
$749,521Michael R Irwin · University Of California Los Angeles · R01 · FY2009 · HL
Ambient light activatable opsin based therapy for age-related macular degeneration
$749,517Samarendra Kumar Mohanty · Nanoscope Technologies, Llc · R44 · FY2021 · EY
New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease
$749,493Franco Vitaliano · Exqor Technologies, Inc. · R44 · FY2019 · AG
The novel role of beta3 integrin in regulating alloimmunity
$749,489Reza Abdi · Brigham And Women'S Hospital · R01 · FY2024 · AI
Resolution of inflammation in chemical-induced cancer
$749,474Dipak Panigrahy · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Mechanisms of lung and cardiac pathology in SARS-CoV-2 infections
$749,419Jacob Yount · Ohio State University · R01 · FY2023 · HL
Mechanism of macrophage efflux system in Mycobacterium tuberculosis pathogenesis
$749,414Murugesan Rajaram · Ohio State University · R56 · FY2024 · AI
Immune determinants of progression from Oral Epithelial Dysplasia to Oral Squamous Cell Carcinoma by precision multiplexed imaging
$749,410Matthew Spitzer · University Of California, San Francisco · R01 · FY2022 · DE